Home Insights
By Dr. Diane Seimetz
Why scientific due diligence is key to a successful M&A
By Jörg Schneider
The field of extracellular vesicles is a nascent and rapidly..
By Kate Coleman, MSc.
The journey to commercialization can be fraught with challenges for organizations...
By Yasser El-Sherbini
Advanced therapeutic medicinal products (ATMPs), better known as cell and gene therapy (CGT) in the United States...
We know the lifechanging impact that gene, cell and tissue-based therapies..
By Alberto Rubio
For years, market access strategies for new therapies almost exclusively depended on data supporting efficacy and safety. ..